The global bioengineered protein drugs market is projected to increase from USD 14.7 billion in 2025 to USD 37.0 billion by 2035, with a CAGR of 9.7% during the forecast period. This strong growth underscores the accelerating adoption of targeted biologic therapies and continuous advancements in protein engineering — two forces reshaping the therapeutic landscape for chronic and...